UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN ISSUER PURSUANT TO RULE 13a-16 AND 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
      For the Month of    __April  2014______
 
 
     File No.   000-54598

Stellar Biotechnologies Inc.
(Name of Registrant)

332 E. Scott Street, Port Hueneme, CA 93041
(Address of Principal executive offices)

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

FORM 20-F     x                                             FORM 40-F       o                

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):    o


Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   o
 
 
 
 
 
 

SIGNATURE

Pursuant to the requirements of the securities Exchange Act of 1934, the registrant has duly caused this Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized.

Stellar Biotechnologies, Inc.
(Registrant)



 
 Dated: _ ___4/1/14________  By: _ /s/ Kathi Niffenegger _ ________________
           Kathi Niffenegger
          Chief Financial Officer
 
 
 

 
 
 
 
Exhibits:

                            99.1 News Release Dated April 1, 2014
 
 
 
 
 
 
 
Stellar Biotechnologies Inc. (NASDAQ:SBOT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Stellar Biotechnologies Inc. Charts.
Stellar Biotechnologies Inc. (NASDAQ:SBOT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Stellar Biotechnologies Inc. Charts.